$3.57
0.00% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US19516Q2084
Symbol
CLGN
Sector
Industry

Collplant Holdings ADR Stock price

$3.57
-0.68 15.97% 1M
-1.43 28.60% 6M
-2.82 44.13% YTD
-2.98 45.50% 1Y
-14.32 80.04% 3Y
-2.23 38.45% 5Y
-14.90 80.67% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.00 0.00%
ISIN
US19516Q2084
Symbol
CLGN
Sector
Industry

Key metrics

Market capitalization $40.89m
Enterprise Value $28.53m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 43.89
P/S ratio (TTM) P/S ratio 62.91
P/B ratio (TTM) P/B ratio 2.42
Revenue growth (TTM) Revenue growth -93.94%
Revenue (TTM) Revenue $650.00k
EBIT (operating result TTM) EBIT $-18.35m
Free Cash Flow (TTM) Free Cash Flow $-13.49m
Cash position $15.61m
EPS (TTM) EPS $-1.52
P/E forward negative
P/S forward 90.67
EV/Sales forward 63.26
Short interest 0.15%
Show more

Is Collplant Holdings ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Collplant Holdings ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Collplant Holdings ADR:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Collplant Holdings ADR:

Buy
100%

Financial data from Collplant Holdings ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.65 0.65
94% 94%
100%
- Direct Costs 3.21 3.21
34% 34%
494%
-2.56 -2.56
131% 131%
-394%
- Selling and Administrative Expenses 3.62 3.62
16% 16%
557%
- Research and Development Expense 11 11
11% 11%
1,706%
-17 -17
187% 187%
-2,657%
- Depreciation and Amortization 1.08 1.08
3% 3%
166%
EBIT (Operating Income) EBIT -18 -18
158% 158%
-2,822%
Net Profit -17 -17
159% 159%
-2,680%

In millions USD.

Don't miss a Thing! We will send you all news about Collplant Holdings ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Collplant Holdings ADR Stock News

Neutral
Seeking Alpha
about one month ago
CollPlant Biotechnologies Ltd (NASDAQ:CLGN ) Q3 2024 Earnings Conference Call November 27, 2024 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Operator Greetings, and welcome to the CollPlant Biotechnologies Third Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode.
Neutral
PRNewsWire
about one month ago
- Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and rapid ingrowth of native tissue -Innovative breast implant technology designed to address a $3.0 billion market opportunity -Cash and cash equivalents balance as of September 30, 2024 was $15.4 million -Co...
Neutral
PRNewsWire
about 2 months ago
- Conference call to be held on Wednesday, November 27, 2024 at 10:00 a.m. U.S. EST - REHOVOT, Israel , Nov. 12, 2024 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced that it will report f...
More Collplant Holdings ADR News

Company Profile

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Yehiel Tal
Employees 75
Founded 2004
Website www.collplant.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today